HCV Replicon Systems: Workhorses of Drug Discovery and Resistance.

Khan, Shaheen; Soni, Shalini; Veerapu, Naga Suresh

Khan, Shaheen; Soni, Shalini; Veerapu, Naga Suresh.

Affiliation

Khan S; Virology Section, Department of Life Sciences, Shiv Nadar University, Gautam Buddha Nagar, India.
Soni S; Virology Section, Department of Life Sciences, Shiv Nadar University, Gautam Buddha Nagar, India.
Veerapu NS; Virology Section, Department of Life Sciences, Shiv Nadar University, Gautam Buddha Nagar, India.

Front Cell Infect Microbiol ; 10: 325, 2020.

Article in En | MEDLINE | ID: mdl-32714881

Subject(s)

Hepacivirus; Hepatitis C, Chronic; Antiviral Agents/pharmacology; Antiviral Agents/therapeutic use; Drug Discovery; Drug Resistance, Viral; Genotype; Hepacivirus/genetics; Hepatitis C, Chronic/drug therapy; Humans; Replicon; Viral Nonstructural Proteins/genetics

Key words

direct-acting antiviral; drug discovery; drug resistance; genotype; hepatitis C virus; replicon; resistance-associated substitution

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepacivirus / Hepatitis C, Chronic Limits: Humans Language: En Journal: Front Cell Infect Microbiol Year: 2020 Type: Article Affiliation country: India

Fulltext

XML

PubMed Links

Search on Google